Inve India ▾

CARE Ratings share price & results

CARE Ratings Limited· Financial Services

Results to
Jun 2026
Latest analysed call
Q4 FY26
Ownership as of
Sept 2026

India's second-largest credit rating agency, rating debt instruments, banks, corporates and sovereigns across a global group.

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue112 ₹ crore+19.1% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin31.0 %+1.0 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit33.0 ₹ crore+26.9% YoYQuarterly, as filedQuarter to Jun 2026Profit after tax as filed.
Return on equity20.42 %+1.7 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin29.60 %+2.7 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)17.75 %−3.4 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Guidance

What management said, and what became of it

6 of 9 judged targets kept · 4 open · verdicts reflect calls analysed to Q4 FY26.

CARE Ratings Limited management guidance track record on Inve: 13 targets tracked across analysed earnings calls (6 achieved, 3 missed, 4 open).

TargetOriginal wordingSaidLatest callVerdict
Ratings Market Share Gainat least 1% per annum over the next 3-4 yearsQ2 FY22Q4 FY26:Management states they continue to hold about a 24%-25% market share in the incremental business, confirming the gains from prior years are being maintained and the promise is fulfilled.
Call transcript, Q4 FY26 · 14 May 2026		Achieved
Non-ratings Business Contribution to Revenue and Earningsone-third of total revenue and earnings coming from non-ratings business by March of 2025Q2 FY22Q4 FY26:Promise concluded in FY25. The new target of 20% is tracked separately under promise 'non-rating-mix-80-20-long-term'.
Call transcript, Q4 FY26 · 14 May 2026		Missed
Non-rating to Rating Business Mixprogressively, we'd like to move towards an 80-20 kind of mix... over a period of timeQ4 FY24Q4 FY26:Non-rating revenue grew to 10.57% of total revenue (vs 10.5% in FY25). While the ratio has not improved significantly, the underlying analytics business has reached breakeven, which management presents as a key step before acceleration.
Call transcript, Q4 FY26 · 14 May 2026		On Track

Source: Inve Guidance Tracker for CARE Ratings Limited · to Q4 FY26

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

3 of CARE Ratings Limited's 13 targets were missed. See which ones, and which are quietly gone. The 3 above are the free sample; 10 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹1,613 +2.09% · +₹33

Last close 27 Oct 2026 · NSE · INR · Source: Inve

Performance +1.9% 1Y

₹1.4k₹1.5k₹1.6k₹1.7k₹1.8kOct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26Q4 FY26 — 14 May 2026

1Y: ₹1,582.3 on 24 Oct 2025 → ₹1,613. High ₹1,800.4 (15 May 2026), low ₹1,412.5 (23 Mar 2026).

Previous close
₹1,580
Market cap
₹4.8k Cr
52-week range
₹1,412.5 – ₹1,800.4
One year
+3.34%
Price to earnings (TTM to Jun 2026)
26.83×
Return on equity (TTM to Jun 2026)
20.42%

Overview

Symbol
NSE:CARERATING
Exchange
NSE
Currency
INR

What CARE Ratings Limited does

Based on the company's own presentations, annual report and earnings calls.

CARE Ratings (CareEdge) assigns credit ratings to bank loans, bonds/NCDs, structured finance instruments, IPOs of REITs/InvITs, and resolution/recovery plans for corporates, financial institutions and infrastructure issuers, earning fee income from issuers for these ratings. Beyond its core domestic ratings business, the group operates non-ratings verticals — analytics, advisory/consulting and ESG ratings — and extends its ratings franchise abroad through wholly/majority-owned subsidiaries covering global scale ratings, Africa and Nepal. The company is licensed by SEBI and accredited by the RBI as a credit rating agency.

Segments

  • Ratings Segment
  • Non-Ratings Segment
Market position
India's 2nd-largest credit rating agency
Cumulative rating assignments
Over 1,01,111
Group structure
6 subsidiaries across ratings, analytics, ESG and global markets
Geographic presence
4 continents
CareEdge Global sovereign coverage
45 sovereigns rated — ranked 4th globally by country coverage
ESG ratings market share
58% market share in Category 1 ESG Rating Provider (Issuer Pays) segment
Founded 1993Headquarters Mumbai, India Company website

How the price took the results

close before → close after

Q4 FY26
+7.9%
14 May

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Your own record

Start an Inve Case for CARE Ratings Limited

Free account: one company. Everything above stays public.

Write why you follow CARE Ratings Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Financial Services companies

All Financial Services companies → · Financial Services earnings growth →

Learn to analyse CARE Ratings Limited

Guides on how to read this kind of business and the numbers that matter.